GlassScriptPhysician profile
Clay Lawrence Hill
NPI 1174956510
$12,852.45
in general payments reported to CMS, 2019-2025
48 companies · $3,604 in 2025
The $3,604 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,868 · 2022: $3,454 · 2023: $2,039 · 2024: $1,888 · 2025: $3,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,674 · Travel and Lodging: $844 · Education: $12.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,674.01 |
| Travel and Lodging | $843.96 |
| Education | $12.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,338.94 | 2021-2025 | Minimed 780g |
| Novo Nordisk INC | $1,278.42 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $1,156.43 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Dexcom, INC. | $844.16 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Amgen INC. | $709.60 | 2021-2025 | Evenity, Tepezza, Prolia |
| Abbott Laboratories | $701.93 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $690.09 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $469.60 | 2021-2025 | Jardiance |
| Esperion Therapeutics, INC. | $415.86 | 2021-2025 | Nexletol, Nexlizet |
| Xeris Pharmaceuticals, INC. | $367.06 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $345.87 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $306.11 | 2021-2025 | |
| Corcept Therapeutics | $287.59 | 2021-2025 | Korlym |
| Recordati_rare_diseases_inc. | $264.29 | 2021-2023 | Isturisa, Signifor Lar |
| Abbvie INC. | $254.09 | 2021-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $201.73 | 2021-2025 | Unithroid |
| Insulet Corporation | $192.70 | 2021-2025 | Omnipod |
| Horizon Therapeutics Plc | $175.04 | 2022-2023 | Tepezza |
| Tandem Diabetes Care, INC. | $173.70 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $158.53 | 2023-2025 | Yorvipath |
| Beta Bionics, INC. | $147.23 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Averitas Pharma INC. | $134.75 | 2023-2024 | Qutenza |
| Grt US Holding, INC. | $134.29 | 2021-2022 | |
| Eusa Pharma (US) LLC | $114.25 | 2022 | |
| Antares Pharma, INC. | $113.77 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Amryt Pharma Holdings LTD | $90.37 | 2022-2023 | Mycapssa, Myalept |
| Amarin Pharma, INC. | $78.64 | 2021 | |
| Tolmar, INC. | $78.02 | 2023-2025 | Jatenzo |
| Astellas Pharma US INC | $69.97 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $62.36 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $50.32 | 2023-2025 | Strensiq |
| Endo Pharmaceuticals INC. | $46.65 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.49 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $43.39 | 2021-2022 | |
| Kyowa Kirin, INC. | $40.94 | 2024 | Crysvita |
| Novartis Pharmaceuticals Corporation | $28.21 | 2022 | |
| Halozyme INC | $26.66 | 2023 | |
| Rhythm Pharmaceuticals, INC. | $26.46 | 2023 | Imcivree |
| Ipsen Biopharmaceuticals, INC | $25.25 | 2023 | Somatuline Depot |
| Sequel Med Tech, LLC | $23.86 | 2025 | Twiist |
| Chiesi USA, INC. | $21.45 | 2025 | Myalept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.54 | 2022 | |
| Nevro Corp. | $19.81 | 2022 | |
| Saluda Medical Americas, INC. | $19.48 | 2024 | Evoke |
| Clarus Therapeutics INC. | $15.57 | 2021 | |
| Acerus Pharmaceuticals Corporation | $14.17 | 2022 | |
| Cequr Corporation | $13.99 | 2024 | Cequr Simplicity |
| Arbor Pharmaceuticals, INC. | $13.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clay Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.